GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 135 filers reported holding GOSSAMER BIO INC in Q4 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,156,000 | +349.3% | 513,793 | +214.0% | 0.00% | +100.0% |
| Q2 2022 | $1,370,000 | -23.2% | 163,626 | -19.8% | 0.00% | 0.0% |
| Q1 2022 | $1,784,000 | -16.1% | 203,936 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $2,127,000 | -8.9% | 206,954 | -6.8% | 0.00% | 0.0% |
| Q3 2021 | $2,335,000 | +25.9% | 221,959 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $1,854,000 | -78.8% | 228,347 | -75.8% | 0.00% | -66.7% |
| Q1 2021 | $8,735,000 | +25.8% | 944,294 | +31.5% | 0.00% | +50.0% |
| Q4 2020 | $6,945,000 | -1.5% | 718,216 | +26.4% | 0.00% | -33.3% |
| Q3 2020 | $7,054,000 | +188.2% | 568,420 | +201.9% | 0.00% | +200.0% |
| Q2 2020 | $2,448,000 | +24.6% | 188,290 | -2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,965,000 | -29.5% | 193,621 | +8.6% | 0.00% | 0.0% |
| Q4 2019 | $2,786,000 | -2.8% | 178,240 | +4.4% | 0.00% | 0.0% |
| Q3 2019 | $2,866,000 | +33.1% | 170,693 | +75.8% | 0.00% | 0.0% |
| Q2 2019 | $2,153,000 | – | 97,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |